AAREY DRUGS & PHARMACEUTICALS LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹48.5
- Today's High:
- ₹50.66
- Open Price:
- ₹50.66
- 52W Low:
- ₹21.9
- 52W High:
- ₹53.49
- Prev. Close:
- ₹50.66
- Volume:
- 10587
Company Statistics
- Market Cap.:
- ₹1.10 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹99.07 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
AAREY DRUGS & PHARMACEUTICALS LTD. had its IPO on under the ticker symbol AREYDRG.
The company operates in the sector and industry. AAREY DRUGS & PHARMACEUTICALS LTD. has a staff strength of 0 employees.
Stock update
Shares of AAREY DRUGS & PHARMACEUTICALS LTD. opened at ₹50.66 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹48.5 - ₹50.66, and closed at ₹48.5.
This is a -4.26% slip from the previous day's closing price.
A total volume of 10,587 shares were traded at the close of the day’s session.
In the last one week, shares of AAREY DRUGS & PHARMACEUTICALS LTD. have slipped by -3.39%.
AAREY DRUGS & PHARMACEUTICALS LTD.'s Key Ratios
AAREY DRUGS & PHARMACEUTICALS LTD. has a market cap of ₹1.10 billion, indicating a price to book ratio of 0.8298 and a price to sales ratio of 0.2109.
In the last 12-months AAREY DRUGS & PHARMACEUTICALS LTD.’s revenue was ₹0 with a gross profit of ₹99.07 million and an EBITDA of ₹0. The EBITDA ratio measures AAREY DRUGS & PHARMACEUTICALS LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, AAREY DRUGS & PHARMACEUTICALS LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q1, AAREY DRUGS & PHARMACEUTICALS LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
AAREY DRUGS & PHARMACEUTICALS LTD.’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 21.7593
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into AAREY DRUGS & PHARMACEUTICALS LTD.’s profitability.
AAREY DRUGS & PHARMACEUTICALS LTD. stock is trading at a EV to sales ratio of 0.2554 and a EV to EBITDA ratio of 10.3467. Its price to sales ratio in the trailing 12-months stood at 0.2109.
AAREY DRUGS & PHARMACEUTICALS LTD. stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹2.91 billion
- Total Liabilities
- ₹1.68 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
AAREY DRUGS & PHARMACEUTICALS LTD. ended 2025 with ₹2.91 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹2.91 billion while shareholder equity stood at ₹1.17 billion.
AAREY DRUGS & PHARMACEUTICALS LTD. ended 2025 with ₹0 in deferred long-term liabilities, ₹1.68 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹7.06 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹43.61 million.
AAREY DRUGS & PHARMACEUTICALS LTD.’s total current assets stands at ₹2.71 billion while long-term investments were ₹0 and short-term investments were ₹4.18 million. Its net receivables were ₹1.90 billion compared to accounts payable of ₹1.27 billion and inventory worth ₹288.19 million.
In 2025, AAREY DRUGS & PHARMACEUTICALS LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, AAREY DRUGS & PHARMACEUTICALS LTD. paid ₹0 in dividends in 2025.
Other key metrics
- Current Trading Price
- ₹48.5
- 52-Week High
- ₹53.49
- 52-Week Low
- ₹21.9
- Analyst Target Price
- ₹
AAREY DRUGS & PHARMACEUTICALS LTD. stock is currently trading at ₹48.5 per share. It touched a 52-week high of ₹53.49 and a 52-week low of ₹53.49. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹41.52 and 200-day moving average was ₹34.32 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.